DT
NERV icon

DV Trading’s Minerva Neurosciences NERV Stock Holding History

DV Trading’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-889,254
Closed -$5.36M – 637
2026
Q1 		$5.36M Buy
+889,254
New +$5.1M 0.13% 67

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DV Trading's NERV Position: Q2 2026 in Review

DV Trading sold out of Minerva Neurosciences (NERV) in Q2 2026, closing a stake of 889,254 shares — an estimated $5.36M sold.

DV Trading first reported a position in NERV in Q1 2026 and held it in 1 quarter. The position peaked at $5.36M in Q1 2026. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • DV Trading reported no remaining Minerva Neurosciences position as of Q2 2026 after selling out during the quarter.
  • DV Trading sold 889,254 Minerva Neurosciences shares in Q2 2026, an estimated $5.36M.
  • DV Trading first reported a position in Minerva Neurosciences in Q1 2026 and held it in 1 quarter.
  • DV Trading's Minerva Neurosciences position peaked at $5.36M in Q1 2026.
  • 60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on DV Trading's 13F filing for Q2 2026, filed 14 Aug 2026.